J 2024

Prenatal MAM exposure raises kynurenic acid levels in the prefrontal cortex of adult rats

FRESCURA, Francesca, Tibor ŠTARK, Edoardo TIZIANI, Serena DI MARTINO, Jana RUDÁ et. al.

Basic information

Original name

Prenatal MAM exposure raises kynurenic acid levels in the prefrontal cortex of adult rats

Name in Czech

Prenatální expozice MAM zvyšuje hladinu kyseliny kynurenové v prefrontální kůře dospělých potkanů

Authors

FRESCURA, Francesca, Tibor ŠTARK, Edoardo TIZIANI, Serena DI MARTINO, Jana RUDÁ, Filippo DRAGO, Luca FERRARO, Vincenzo MICALE and Sarah BEGGIATO

Edition

PHARMACOLOGICAL REPORTS, HEIDELBERG, SPRINGER HEIDELBERG, 2024, 1734-1140

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 4.400 in 2022

Organization unit

Faculty of Medicine

UT WoS

001236296000001

Keywords in English

AM251;Novel object recognition test;Kynurenine Pathway;Haloperidol;Peripubertal treatment;Schizophrenia

Tags

Tags

International impact, Reviewed
Změněno: 10/6/2024 13:44, Mgr. Tereza Miškechová

Abstract

V originále

The present findings suggest that the cognitive deficit observed in MAM rats may be related to enhanced PFC KYNA levels which could be, in turn, mediated by the activation of cannabinoid CB1 receptor. These results further support the modulation of brain KYNA levels as a potential therapeutic strategy to ameliorate the cognitive dysfunctions in schizophrenia.

Links

MUNI/A/1580/2023, interní kód MU
Name: Preklinický a klinický výzkum Farmakologického ústavu v oblasti biotrasformace léčiv, behaviorální neuropsychofarmakologie a personalizované farmakoterapie v onkologii
Investor: Masaryk University, Preclinical and clinical research of the Department of Pharmacology in the field of biotransformation of drugs, behavioural neuropsychopharmacology and personalized pharmacotherapy in oncology